the hospital has announced. Wegovy is approved for children above 12 years old and it will be used to supplement existing treatments for children with severe obesity and comorbidities. Although the hospital agrees to the usage, being the second regional hospital to administer the drug after the Capital Region, Randers Regional Hospital isn’t too keen and is particularly concerned about the children’s growth. A department head from Randers Regional Hospital went on to say that the drug’s long-term side effects have not been documented well and there could be other health risks involved.
- Wegovy is available in pens and injected into the skin once a week. It is only available with a prescription.
- The active substance in the Novo Nordisk drug, semaglutide, works the same way as hormones in a body would, among other things, increase the feeling of satiety.
- Studies have shown that Wegovy can help obese people shed 17% of their weight after about a year.
- Frequent side effects of the drug are headache, nausea and vomiting, diarrhea, constipation and abdominal pain.
